Establishment of Immune Biobank for Vaccine Immunogenicity Prediction Using In Vitro and In Silico Methods Against Porcine Reproductive and Respiratory Syndrome Virus
The PRRSV immune bank demonstrated potential as a tool for predicting vaccine immunogenicity against different PRRSV-2 strains and EpiCC provides additional information on T cell epitope cross conservation. The combined approach may provide a valuable framework for selecting PRRSV vaccines for more effective prevention and control in endemic areas.
Authors
- Chaitawat Sirisereewan (ORCID: https://orcid.org/0000-0002-2959-3618)
- John J. Byrne (ORCID: https://orcid.org/0000-0001-7845-6364)
- Elisa Crisci (ORCID: https://orcid.org/0000-0002-4235-8508)
- Glen W. Almond (ORCID: https://orcid.org/0000-0003-3210-6718)
- Benjamin Gabriel (ORCID: https://orcid.org/0000-0003-0762-9082)
- Ben M. Hause
- Gustavo Machado (ORCID: https://orcid.org/0000-0001-7552-6144)
- Tobias Käser (ORCID: https://orcid.org/0000-0001-8764-7971)
- Anne S. De Groot (ORCID: https://orcid.org/0000-0001-5911-1459)
- Juliana Ferreira (ORCID: https://orcid.org/0000-0002-8611-808X)
- Abigail Williams (ORCID: https://orcid.org/0009-0003-7626-159X)
- Lanre Sulaiman
Institutions
- North Carolina State University (US)
- University of Veterinary Medicine Vienna (AT)
- Providence College (US)
- Minnesota West Community & Technical College (US)
- EpiVax (United States) (US)
Publication Details
- Journal
- Vaccines
- Published
- 2025-10-14
- DOI
- https://doi.org/10.3390/vaccines13101052
- Primary Topic
- Animal Virus Infections Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- North Carolina State University
- Smithfield Foods